The Progression of Type 2 Diabetes and the Treatment Options to Manage It

In this AJMC peer discussion moderated by Peter Salgo, MD, a panel of experts review novel agents in the treatment plan for glycemic control in Type 2 diabetes.

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

The Future of Managing Type 2 Diabetes
June 26, 2019 – 
Panelists provide their final thoughts on the future treatment landscape of type 2 diabetes.
Combinations in the Treatment of Type 2 Diabetes
June 19, 2019 – 
Experts discuss combinations in the treatment of diabetes, and the practical implications of these potential combinations for patients and physicians.
Real-World Factors in the Treatment of Diabetes
June 19, 2019 – 
Additional real-world considerations for the treatment of type 2 diabetes with the newer classes of drugs.
Safety Concerns in New Class of Drugs for Diabetes
June 12, 2019 – 
A discussion on the management of adverse effects for each of the 3 new drug classes in the treatment of type 2 diabetes.
Coverage Considerations for Novel Agents in Diabetes
June 12, 2019 – 
Considerations for the coverage of new higher-cost drugs by health insurance plans for the treatment of diabetes and prevention of kidney disease.
New Treatment Classes for Type 2 Diabetes
June 05, 2019 – 
Reviewing the mechanisms of action of the new treatments available for type 2 diabetes.
 
Progression of Treatment in Diabetes
May 29, 2019 – 
Examining the progression of treatment for diabetes and the increasing costs for the patient based on evolving health care benefits.
The Pharmacological Treatment of Diabetes
May 29, 2019 – 
A review of the available pharmacological options for the treatment of diabetes, and an examination of the recent increase in the price of insulin.
 
The Nonpharmacological Treatment of Diabetes
May 22, 2019 – 
Nonpharmacological approaches toward the prevention and treatment of prediabetes and diabetes.
The Economic Burden of Diabetes in the US
May 22, 2019 – 
Panelists review the huge economic burden of diabetes within the United States of America.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.